APPLICATION SITE SCAB side effect
What is APPLICATION SITE SCAB ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
APPLICATION SITE SCAB and Recently Reported Side Effects
APPLICATION SITE SCAB and 15 most Active Side Effect polls
APPLICATION SITE SCAB and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Abreva Side Effects Report #5461641-6
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Nov 17, 2006. Female patient, 56 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site scab, . ABREVA dosage: unknown. Patient recovered.
Abreva Side Effects Report #5461815-4
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 22, 2006. Female patient, 52 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site scab, oral herpes, . ABREVA dosage: unknown. Patient recovered.
Abreva Side Effects Report #5461818-X
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Dec 22, 2006. Female patient, 27 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site scab, . ABREVA dosage: unknown. Patient recovered.
Abreva Side Effects Report #5462027-0
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 08, 2007. Female patient, 77 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site scab, . ABREVA dosage: unknown. Patient recovered.
Abreva Side Effects Report #5462286-4
Consumer or non-health professional from UNITED STATES reported ABREVA problem on June 18, 2007. Female patient, 22 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site scab, lip pain, lip swelling, oral herpes, . ABREVA dosage: unknown. Patient recovered.
Abreva Side Effects Report #5462659-X
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Female patient, 59 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site scab, application site scar, oral herpes, . ABREVA dosage: unknown. Patient recovered.
Abreva Side Effects Report #5462663-1
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Feb 20, 2007. Female patient, 67 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site scab, . ABREVA dosage: unknown. Patient recovered.
Abreva Side Effects Report #5462845-9
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 02, 2007. Female patient, 51 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site scab, . ABREVA dosage: unknown. Patient recovered.
Aldara Side Effects Report #5424387-6
Consumer or non-health professional from CANADA reported ALDARA problem on Aug 14, 2007. Male patient, 82 years of age, weighting 169.0 lb, was diagnosed with precancerous cells present and was treated with ALDARA. After drug was administered, patient experienced the following problems/side effects: application site scab, fatigue, gait disturbance, pyrexia, speech disorder, . ALDARA dosage: unknown. During the same period patient was treated with CRESTOR, RANITIDINE, ACETAMINOPHEN, ASPIRIN, DEXTROMETHORPHAN, DOXYLAMINE SUCCINATE, NYQUIL. Patient was hospitalized. Patient recovered.
Bengay Side Effects Report #5590674-4
BENGAY PAIN RELIEVING PATCH problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 02, 2008. Male patient, 27 years of age, weighting 170.0 lb, was diagnosed with pain in extremity and was treated with BENGAY PAIN RELIEVING PATCH. After drug was administered, patient experienced the following problems/side effects: application site burn, application site scab, application site vesicles, burns second degree, . BENGAY PAIN RELIEVING PATCH dosage: unknown. Patient was hospitalized. Patient recovered.
Abreva Side Effects Report #5462141-X
Consumer or non-health professional from UNITED STATES reported ABREVA problem on May 08, 2007. Female patient, 67 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site scab, chapped lips, lip pain, . ABREVA dosage: unknown. Patient recovered.
Abreva Side Effects Report #5462494-2
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 22, 2007. Male patient, 49 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site scab, oral herpes, . ABREVA dosage: unknown. Patient recovered.
Abreva Side Effects Report #5462645-X
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Feb 14, 2007. Female patient, 28 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site scab, . ABREVA dosage: unknown. Patient recovered.
Abreva Side Effects Report #5462727-2
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 01, 2007. Female patient, child 11 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site infection, application site scab, . ABREVA dosage: unknown. Patient recovered.
Duragesic Side Effects Report #5734713-6
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on May 01, 2008. Female patient, weighting 130.0 lb, was diagnosed with back pain, sleep disorder and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: anxiety, application site scab, application site scar, eczema, pancreatitis acute, . DURAGESIC dosage: unknown. During the same period patient was treated with AMITRIPTLINE. Patient was hospitalized. Patient recovered.
Daytrana Side Effects Report #5653738-2
DAYTRANA problem was reported by a Physician from UNITED STATES on Nov 19, 2007. Male patient, child 12 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site excoriation, application site irritation, application site scab, dermatitis contact, . DAYTRANA dosage: 20 MG, 1X/DAY:QD; 20 MG, 1X/DAY:QD, TRANSDERMAL. Patient recovered.
Aldara Side Effects Report #5534006-6
Physician from UNITED STATES reported ALDARA problem on Nov 16, 2007. Male patient was diagnosed with basal cell carcinoma, biopsy and was treated with ALDARA. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site scab, incorrect dose administered, . ALDARA dosage: unknown. Patient died.
Abreva Side Effects Report #5462323-7
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2007. Female patient, 70 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site pain, application site scab, application site swelling, oral herpes, . ABREVA dosage: unknown. Patient recovered.
Abreva Side Effects Report #5462353-5
Consumer or non-health professional from UNITED STATES reported ABREVA problem on July 05, 2007. Female patient, 37 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site dryness, application site scab, lip pain, lip swelling, . ABREVA dosage: unknown. Patient recovered.
Aldara Side Effects Report #5420862-9
ALDARA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 13, 2007. Female patient, 68 years of age, weighting 145.0 lb, was diagnosed with basal cell carcinoma, biopsy and was treated with ALDARA. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site irritation, application site scab, blood pressure increased, bronchitis, haematochezia, oral herpes, urinary tract infection, . ALDARA dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, TENORMIN, NIFEDIPINE, CLONIDINE, PRINIVIL. Patient was hospitalized. Patient recovered.
Duragesic Side Effects Report #5742843-8
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on May 09, 2008. Male patient, weighting 178.0 lb, was diagnosed with pain, convulsion, gastric disorder and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site reaction, application site scab, heart rate decreased, hypotension, skin disorder, somnolence, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, ACTIQ, KLONOPIN, PREVACID. Patient was hospitalized. Patient recovered.
Duragesic Side Effects Report #5753606-1
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2008. Male patient, weighting 178.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site reaction, application site scab, fatigue, heart rate decreased, hypotension, skin disorder, skin haemorrhage, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, FENTANYL TRANSDERMAL SYSTEM, FENTANYL TRANSDERMAL SYSTEM, FENTANYL TRANSDERMAL SYSTEM, ACTIQ. Patient was hospitalized. Patient recovered.